Skip to main content
FinSpry Logo
FinSpry
ANL logo
ANL
(NASDAQ)
Adlai Nortye Ltd.
$15.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Adlai Nortye (ANL) Stock Price & Financial Analysis

Adlai Nortye Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.55 - $16.02
52-Week High$17.25
52-Week Low$0.88
Open$14.69
Volume308.56K
Average Volume (3M)154.16K
Market Cap479.94M
Shares Outstanding31.97M
Price to Sales (P/S)73.95
Price to Book (P/B)-57.67
EV/EBITDA-7.83
Revenue (TTM)6.49M
Net Income (TTM)-54.06M
Free Cash Flow (TTM)-66.94M
EPS (TTM)$-6.97
Profit Margin-833.05%
Operating Margin-996.44%
50-Day MA$12.55
200-Day MA$9.00
52-Week Change757.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Adlai Nortye

What is the current stock price for ANL?

As of the latest trading session, ANL stock trades at $15.01. The 52-week range is $0.88–$17.25, with a day range of $14.55–$16.02.

What is the P/E ratio for ANL?

The P/E ratio (Price-to-Earnings) for ANL is shown in the Key Statistics section. This valuation metric helps compare Adlai Nortye Ltd. to industry peers.

Does ANL pay dividends?

Adlai Nortye does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ANL?

Based on 1 analyst, the consensus for ANL is Buy.

What is the market cap of ANL?

Adlai Nortye's market capitalization is $479.9M, classifying it as a small-cap company. Adlai Nortye operates in the Healthcare sector within the Biotechnology industry.